Home » Topics » BioWorld Science

BioWorld Science
RSS

Domainex patents new IKK-E, TBK1 and SIK2 kinase inhibitors

Sep. 10, 2018

Daiichi Sankyo discovers bacterial tryptophanase inhibitors

Sep. 10, 2018

Korean researchers synthesize new LRRK2 inhibitors

Sep. 10, 2018

Sichuan Kelun-Biotech Biopharmaceutical divulges MAP3K5 inhibitors

Sep. 10, 2018

Different vaccination routes lead to different protection

Sep. 10, 2018

Carbon dioxide aggravates COPD

Sep. 10, 2018

Host changes after Zika virus infection

Sep. 10, 2018

Neutrophil-lookalike membranes fight arthritis

Sep. 10, 2018

Microbiome metabolites and host responses

Sep. 10, 2018

When a bear spits in the woods

Sep. 10, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...